-
1
-
-
0030598673
-
-
For examples, see : (a)
-
For examples, see : (a) Damour, D.; Barreau, M.; Blanchard, J-C.; Burgevin, M-C.; Doble, A.; Herman, F.; Pantel, G.; James-Surcouf, E.; Vuilhorgne, M.; Mignani, S.; Poitout, L.; Le Merrer, Y.; Depezay, J-C. Bioorg. Med. Chem. Lett. 1996, 6, 1667-1672;
-
(1996)
Bioorg. Med. Chem. Lett.
, vol.6
, pp. 1667-1672
-
-
Damour, D.1
Barreau, M.2
Blanchard, J.-C.3
Burgevin, M.-C.4
Doble, A.5
Herman, F.6
Pantel, G.7
James-Surcouf, E.8
Vuilhorgne, M.9
Mignani, S.10
Poitout, L.11
Le Merrer, Y.12
Depezay, J.-C.13
-
2
-
-
0032561511
-
-
(b) Rohrer, S.P.; Birzin, E.T.; Mosley, R.T.; Berk, S.C.; Hutchins, S.M.; Shen, D.M.; Xiong, Y.; Hayes, E.C.; Parmar, R.M.; Foor, F.; Mitra, S.W.; Degrado, S.J.; Shu, M.; Klopp, J.M.; Cai, S.J.; Blake, A.; Chan; W.W.S.; Pasternak, A.; Yang, L.; Patchett, A.A.; Smith, R.G.; Chapman, K.T.; Schaeffer, J.M. Science 1998, 282, 737-740;
-
(1998)
Science
, vol.282
, pp. 737-740
-
-
Rohrer, S.P.1
Birzin, E.T.2
Mosley, R.T.3
Berk, S.C.4
Hutchins, S.M.5
Shen, D.M.6
Xiong, Y.7
Hayes, E.C.8
Parmar, R.M.9
Foor, F.10
Mitra, S.W.11
Degrado, S.J.12
Shu, M.13
Klopp, J.M.14
Cai, S.J.15
Blake, A.16
Chan, W.W.S.17
Pasternak, A.18
Yang, L.19
Patchett, A.A.20
Smith, R.G.21
Chapman, K.T.22
Schaeffer, J.M.23
more..
-
3
-
-
0032564880
-
-
(c) Ankersen, M.; Crider, M.; Liu, S.; Ho, B.; Andersen, H.S.; Stidsen, C. J. Am. Chem. Soc. 1998, 120, 1368-1373;
-
(1998)
J. Am. Chem. Soc.
, vol.120
, pp. 1368-1373
-
-
Ankersen, M.1
Crider, M.2
Liu, S.3
Ho, B.4
Andersen, H.S.5
Stidsen, C.6
-
4
-
-
15444348498
-
-
(g) Yang, L.; Guo, L.; Pasternak, A.; Mosley, R.; Rohrer, S.; Birzin, E.; Foor, F.; Cheng, K.; Schaeffer, J.; Patchett, A.A. J. Med. Chem. 1998, 41, 2175-2179.
-
(1998)
J. Med. Chem.
, vol.41
, pp. 2175-2179
-
-
Yang, L.1
Guo, L.2
Pasternak, A.3
Mosley, R.4
Rohrer, S.5
Birzin, E.6
Foor, F.7
Cheng, K.8
Schaeffer, J.9
Patchett, A.A.10
-
5
-
-
0027202613
-
-
(a) Hobbs De Witt, S.; Kiely, J.K.; Stankovic, C.J.; Schroeder, M.C.; Cody, D.M.R.; Pavia, M.R. Proc. Nad. Acad. Sci. USA 1993, 90, 6909-6913;
-
(1993)
Proc. Nad. Acad. Sci. USA
, vol.90
, pp. 6909-6913
-
-
Hobbs De Witt, S.1
Kiely, J.K.2
Stankovic, C.J.3
Schroeder, M.C.4
Cody, D.M.R.5
Pavia, M.R.6
-
7
-
-
0028278170
-
-
(c) Burnin, B.A.; Plunkett, M.J.; Ellman, J.A. Proc. Natl. Acad. Sci. USA 1994, 91, 4708-4712;
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 4708-4712
-
-
Burnin, B.A.1
Plunkett, M.J.2
Ellman, J.A.3
-
9
-
-
0000512227
-
-
(e) Armstrong, R.W.; Combs, A.P.; Tempest, P.A.; Brown, S.O.; Keating, T.A. Acc. Chem. Res. 1996, 29, 123-131;
-
(1996)
Acc. Chem. Res.
, vol.29
, pp. 123-131
-
-
Armstrong, R.W.1
Combs, A.P.2
Tempest, P.A.3
Brown, S.O.4
Keating, T.A.5
-
12
-
-
0000074870
-
-
(h) Gordon, E.M.; Gallop, M.A.; Patel, D.V. Acc. Chem. Res. 1996, 29, 144-154.
-
(1996)
Acc. Chem. Res.
, vol.29
, pp. 144-154
-
-
Gordon, E.M.1
Gallop, M.A.2
Patel, D.V.3
-
13
-
-
0030770084
-
-
(a) Katritzky, A.R.; Xie, L.; Zhang, G.; Griffith, M.; Watson, K.; Kiely, J.S. Tetrahedron Lett. 1997, 38, 7011-7014;
-
(1997)
Tetrahedron Lett.
, vol.38
, pp. 7011-7014
-
-
Katritzky, A.R.1
Xie, L.2
Zhang, G.3
Griffith, M.4
Watson, K.5
Kiely, J.S.6
-
14
-
-
85047674714
-
-
(b) Dankwardt, S.M.; Newman, S.R.; Krstenansky, J.L. Tetrahedron Lett. 1995, 36, 4923-4926
-
(1995)
Tetrahedron Lett.
, vol.36
, pp. 4923-4926
-
-
Dankwardt, S.M.1
Newman, S.R.2
Krstenansky, J.L.3
-
15
-
-
0028261065
-
-
Previous studies on the synthesis of enantiopure azepanes from bis-epoxides : (a)
-
Previous studies on the synthesis of enantiopure azepanes from bis-epoxides : (a) Poitout, L.; Le Merrer, Y.; Depezay, J-C. Tetrahedron Lett. 1994, 35, 3293-3296;
-
(1994)
Tetrahedron Lett.
, vol.35
, pp. 3293-3296
-
-
Poitout, L.1
Le Merrer, Y.2
Depezay, J.-C.3
-
16
-
-
0029088080
-
-
(b) Lohray, B.B.; Jayamma, Y.; Chatterjee, M. J. Org. Chem. 1995, 60, 5958-5960.
-
(1995)
J. Org. Chem.
, vol.60
, pp. 5958-5960
-
-
Lohray, B.B.1
Jayamma, Y.2
Chatterjee, M.3
-
17
-
-
85083151843
-
-
Deprotection was carried out by 30% piperidine in DMF.
-
Deprotection was carried out by 30% piperidine in DMF.
-
J. Org. Chem.
-
-
-
18
-
-
84944166508
-
-
The amine 8 was prepared from the commercialy available Fmoc-Rink linker by amidification with benzylamine in presence of DCC and N,N-diisopropylethylamine, and subsequent Fmoc removal with piperidine in THF.
-
The amine 8 was prepared from the commercialy available Fmoc-Rink linker by amidification with benzylamine in presence of DCC and N,N-diisopropylethylamine, and subsequent Fmoc removal with piperidine in THF.
-
J. Org. Chem.
-
-
-
19
-
-
84944166508
-
-
The formation of the desired azepane was indicated by the disappearance of the free amine of the linker. In order to quantify reaction yields directly on beads, we have used a protocol involving ninhydrin.
-
The formation of the desired azepane was indicated by the disappearance of the free amine of the linker. In order to quantify reaction yields directly on beads, we have used a protocol involving ninhydrin.
-
J. Org. Chem.
-
-
-
20
-
-
85083139550
-
-
2O (2 × 10 mL), then dried under reduced pressure to give 2. Resin loading of "Rink-azepane resin" 1 was determined to be 0.23 mmol/g by ninhydrin test.
-
2O (2 × 10 mL), then dried under reduced pressure to give 2. Resin loading of "Rink-azepane resin" 1 was determined to be 0.23 mmol/g by ninhydrin test.
-
J. Org. Chem.
-
-
-
21
-
-
85083138655
-
-
Degradation has been confirmed by heating the deprotected Rink resin in DMF at 80°C during 2, 5 or 7 days. Treatment of each batch with N-Fmoc glycine (DIC, DMAP) and subsequent measurement of the Fmoc group introduced allowed to quantify the remaining free amino group after heating. The ratio of remaining amine relative to the initial quantity was respectively 87, 35 or 26% after heating during 2, 5 or 7 days.
-
Degradation has been confirmed by heating the deprotected Rink resin in DMF at 80°C during 2, 5 or 7 days. Treatment of each batch with N-Fmoc glycine (DIC, DMAP) and subsequent measurement of the Fmoc group introduced allowed to quantify the remaining free amino group after heating. The ratio of remaining amine relative to the initial quantity was respectively 87, 35 or 26% after heating during 2, 5 or 7 days.
-
J. Org. Chem.
-
-
-
22
-
-
85083137621
-
-
For example, without caping free amines, the azepane 4 isolated after benzoylation and cleavage was contamined with benzamide.
-
For example, without caping free amines, the azepane 4 isolated after benzoylation and cleavage was contamined with benzamide.
-
J. Org. Chem.
-
-
-
23
-
-
85004775207
-
-
Bolin, D.R.; Sytwu, I.I.; Humiec, F.; Meienhofer, J. Int. J. Peptide Protein Res. 1989, 33, 353-359.
-
(1989)
Int. J. Peptide Protein Res.
, vol.33
, pp. 353-359
-
-
Bolin, D.R.1
Sytwu, I.I.2
Humiec, F.3
Meienhofer, J.4
-
24
-
-
85083149522
-
-
2O (2 × 1 mL) and drying under reduced pressure. After protection of the remaining free amines as carbamates, only 0.07 mmol/g of Rink-linker remains free.
-
2O (2 × 1 mL) and drying under reduced pressure. After protection of the remaining free amines as carbamates, only 0.07 mmol/g of Rink-linker remains free.
-
Int. J. Peptide Protein Res.
-
-
|